Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5141750 | TrAC Trends in Analytical Chemistry | 2016 | 34 Pages |
Abstract
Therapeutic drug monitoring (TDM) is a tool used to integrate pharmacokinetic and pharmacodynamic knowledge to optimise and personalize drug therapy. TDM is of specific interest for anti-infectives: to assure adequate drug exposure and reduce adverse events, to increase patient compliance and to prevent antimicrobial resistance. For TDM, drug blood concentrations are determined to bring and keep the concentration within the targeted therapeutic range. Currently, LC-MS/MS is the primary analytical technique for fast and accurate quantification of anti-infective drug concentrations. In addition to blood, several alternative matrices (cerebrospinal fluid, inflammatory fluids, specific cells and tissue) and alternative sampling strategies (dried blood spot and saliva) are currently being explored and introduced to support TDM. Here, we review the current challenges in the bioanalysis of anti-infective drugs and give insight in the pre- and postanalytical issues surrounding TDM.
Keywords
CmaxDBSTDMMICCminSPELLOQAMSELFLLEAUCLC-MS/MSPK/PDMatrix effectsSolid-phase extractionLiquid-liquid extractionProficiency testinglower limit of quantificationMinimum inhibitory concentrationmaximum concentrationAnti-infectivesHigh performance liquid chromatography tandem mass spectrometryLiquid chromatography-tandem mass spectrometry (LC-MS/MS)Epithelial lining fluidCerebrospinal fluidCSFarea under the curvetherapeutic drug monitoringAntimicrobial stewardshipTherapeutic drug monitoring (TDM)Dried blood spothuman immunodeficiency virusHIVhigh performance liquid chromatographyHPLCquality control
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Anette Veringa, Marieke G.G. Sturkenboom, Bart G.J. Dekkers, Remco A. Koster, Jason A. Roberts, Charles A. Peloquin, Daan J. Touw, Jan-Willem C. Alffenaar,